IL1B and Fabry disease: Colchicine exerts its anti-inflammatory effects by preventing migration and adhesion of neutrophils and suppressing the NLRP3 inflammasome, decreasing IL-1β and IL-6 production, cytokines implicated in the pathophysiology of FD [162].